You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SYK inhibitor

Showing 1 - 25 of 7,382
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in United States (Lanraplenib,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +3 more
Aug 4, 2022

DLBCL, DLBCL Activated B-Cell Type, DLBCL Germinal Center B-Cell Type Trial in Chicago (Cyclophosphamide, Doxorubicin

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Chicago, Illinois
    Northwestern University
Apr 30, 2021

Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)

Recruiting
  • Refractory Chronic Myelomonocytic Leukemia
  • Refractory Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Aug 31, 2021

Immune Thrombocytopenia (ITP) Trial in Tianjin (HMPL-523, Placebo)

Unknown status
  • Immune Thrombocytopenia (ITP)
  • Tianjin, Tianjin, China
    Blood diseases hospital, Chinese academy of medical university
Oct 20, 2020

Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)

Completed
  • Anemia
  • +13 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 29, 2021

Immune Thrombocytopenia Trial in Worldwide (SKI-O-703, Placebo oral tablet)

Unknown status
  • Immune Thrombocytopenia
  • Los Angeles, California
  • +26 more
Sep 16, 2020

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)

Active, not recruiting
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Jan 31, 2023

Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Immune Mediated Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Fostamatinib in Patients With ITP. FOSTASUR Study

Completed
  • Primary Immune Thrombocytopenia
  • Cadiz, Cádiz, Spain
  • +13 more
Oct 3, 2023

Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting
  • Sickle Cell Disease
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 21, 2023

Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Immune Mediated Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Nucleophosmin 1-mutated Acute Myeloid Leukemia Trial in Worldwide (Entospletinib, Placebo, Cytarabine)

Recruiting
  • Nucleophosmin 1-mutated Acute Myeloid Leukemia
  • Duarte, California
  • +60 more
Jul 20, 2022

Genetic and Functional Analysis of Cherubism

Recruiting
  • Cherubism
    • Farmington, Connecticut
      University of Connecticut Health Center
    Jan 24, 2022

    Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

    Active, not recruiting
    • Prolymphocytic Leukemia
    • +4 more
    • Columbus, Ohio
    • +1 more
    Apr 29, 2022

    Coronavirus Disease 2019 Trial in Bethesda, Falls Church (Placebo, fostamatinib)

    Completed
    Has Results
    • Coronavirus Disease 2019
    • Bethesda, Maryland
    • +1 more
    Feb 28, 2022

    Plasmodium Falciparum Malaria Trial in Huong Hoa (Imatinib combination therapy, Dihydroartemisinin-piperaquine)

    Completed
    • Plasmodium Falciparum Malaria
    • Huong Hoa, Quang Tri, Vietnam
      A Tuc
    Feb 8, 2021

    Peripheral T-Cell Lymphoma (PTCL NOS), Nodal Lymphomas of T Follicular Helper (TFH), Follicular T-cell Lymphoma (FTCL) Trial

    Withdrawn
    • Peripheral T-Cell Lymphoma (PTCL NOS)
    • +8 more
    • (no location specified)
    Mar 10, 2020

    Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing/China, China
    • +1 more
    Oct 9, 2023

    CLL Trial in Denmark, Netherlands, Sweden (Acalabrutinib, Venetoclax)

    Recruiting
    • CLL
    • Copenhagen, Denmark
    • +5 more
    Sep 17, 2021

    Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Cutaneous T-cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 8, 2023

    Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

    Not yet recruiting
    • Cervical Cancer
    • Anti-PD-1 antibody balstilimab
    • Amsterdam, Netherlands
      Amsterdam UMC
    Oct 17, 2023

    Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

    Recruiting
    • Hepatocellular Carcinoma (HCC)
    • Kaohsiung, Taiwan
    • +4 more
    Mar 14, 2023

    HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

    Not yet recruiting
    • HIV Infections
    • Las Vegas, Nevada
    • +1 more
    Aug 21, 2023

    Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • (no location specified)
    Aug 31, 2023